Phoenix Biotech Acquisition (PBAX) Short Interest Ratio & Short Volume → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free PBAX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisHeadlinesOwnershipShort InterestSocial MediaStock AnalysisHeadlinesOwnershipShort InterestSocial Media Phoenix Biotech Acquisition Short Interest DataCurrent Short Volume800 sharesPrevious Short Volume2,600 sharesChange Vs. Previous Month-69.23%Dollar Volume Sold Short$8,808.00Short Interest Ratio / Days to Cover0.1Last Record DateJanuary 31, 2024Outstanding Shares6,250,000 sharesFloat Size950,000 sharesShort Percent of Float0.08%Today's Trading Volume6,400 sharesAverage Trading Volume16,686 sharesToday's Volume Vs. Average38% Short Selling Phoenix Biotech Acquisition ? Sign up to receive the latest short interest report for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPBAX Short Interest Over TimePBAX Days to Cover Over TimePBAX Percentage of Float Shorted Over Time Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Phoenix Biotech Acquisition Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2024800 shares $8,808.00 -69.2%0.1%0.1 $11.01 1/15/20242,600 shares $28,990.00 -10.3%0.3%1.2 $11.15 12/31/20232,900 shares $31,900.00 +61.1%0.3%1.5 $11.00 12/15/20231,800 shares $19,638.00 -5.3%0.2%0.9 $10.91 11/30/20231,900 shares $20,653.00 +46.2%0.0%4.8 $10.87 11/15/20231,300 shares $14,183.00 +8.3%0.0%4.3 $10.91 Get the Latest News and Ratings for PBAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. 10/31/20231,200 shares $13,044.00 -7.7%0.1%3 $10.87 10/15/20231,300 shares $14,170.00 -31.6%0.1%3.3 $10.90 9/30/20231,900 shares $20,634.00 +280.0%0.1%2.4 $10.86 9/15/2023500 shares $5,400.00 -54.6%0.0%0.1 $10.80 8/31/20231,100 shares $11,891.00 +120.0%0.1%0.2 $10.81 8/15/2023500 shares $5,475.00 -37.5%0.0%0.1 $10.95 7/31/2023800 shares $8,624.00 -77.8%0.1%0.1 $10.78 7/15/20233,600 shares $38,988.00 +350.0%0.2%0.6 $10.83 6/30/2023800 shares $8,720.00 +700.0%0.1%0.1 $10.90 6/15/2023100 shares $1,081.00 -90.9%0.0%0 $10.81 5/31/20231,100 shares $11,880.00 +266.7%0.1%0.3 $10.80 5/15/2023300 shares $3,258.00 No Change0.0%0.1 $10.86 4/30/2023300 shares $3,315.00 -95.0%0.0%0.1 $11.05 4/15/20236,000 shares $64,260.00 No Change0.4%1.4 $10.71 3/31/20236,000 shares $64,080.00 -1.6%0.3%1.5 $10.68 3/15/20236,100 shares $65,148.00 -16.4%0.0%3.8 $10.68 2/28/20237,300 shares $76,869.00 -4.0%0.0%1.8 $10.53 2/15/20237,600 shares $80,636.00 +4.1%0.0%0.6 $10.61 1/31/20237,300 shares $76,796.00 -6.4%0.0%0.3 $10.52 1/15/20237,800 shares $81,354.00 -14.3%0.0%0.3 $10.43 12/30/20229,100 shares $93,459.73 -18.0%0.1%0.3 $10.27 12/15/202211,100 shares $114,330.00 +105.6%0.1%0.3 $10.30 11/30/20225,400 shares $55,296.00 -95.9%0.0%0.1 $10.24 11/15/2022130,300 shares $1.33 million +5,565.2%0.8%3.6 $10.20 10/31/20222,300 shares $23,391.00 -14.8%0.0%0.1 $10.17 10/15/20222,700 shares $27,324.00 -71.6%0.0%0.1 $10.12 9/30/20229,500 shares $95,855.00 +280.0%0.1%0.2 $10.09 9/15/20222,500 shares $25,175.00 -45.7%0.0%0 $10.07 8/31/20224,600 shares $46,322.00 +109.1%0.0%0.1 $10.07 8/15/20222,200 shares $22,198.00 -69.9%0.0%0 $10.09 7/31/20227,300 shares $73,438.00 +40.4%0.0%0.2 $10.06 7/15/20225,200 shares $52,312.00 +188.9%0.0%0.1 $10.06 6/30/20221,800 shares $18,036.00 -59.1%0.0%0 $10.02 6/15/20224,400 shares $44,132.00 -75.8%0.0%0.1 $10.03Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> PBAX Short Interest - Frequently Asked Questions What is Phoenix Biotech Acquisition's current short interest? Short interest is the volume of Phoenix Biotech Acquisition shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 800 shares of PBAX short. 0.08% of Phoenix Biotech Acquisition's shares are currently sold short. Learn More on Phoenix Biotech Acquisition's current short interest. What is a good short interest percentage for Phoenix Biotech Acquisition? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Phoenix Biotech Acquisition's floating shares are currently sold short. Is Phoenix Biotech Acquisition's short interest increasing or decreasing? Phoenix Biotech Acquisition saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 800 shares, a decline of 69.2% from the previous total of 2,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Phoenix Biotech Acquisition's float size? Phoenix Biotech Acquisition currently has issued a total of 6,250,000 shares. Some of Phoenix Biotech Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Phoenix Biotech Acquisition currently has a public float of 950,000 shares. How does Phoenix Biotech Acquisition's short interest compare to its competitors? 0.08% of Phoenix Biotech Acquisition's shares are currently sold short. Here is how the short interest of companies compare to Phoenix Biotech Acquisition: Qomolangma Acquisition Corp. (0.03%), Mountain Crest Acquisition Corp. V (0.03%), Banyan Acquisition Co. (0.23%), Broad Capital Acquisition Corp. (0.01%), Western Acquisition Ventures Corp. (0.92%), Cetus Capital Acquisition Corp. (0.01%), Yotta Acquisition Co. (0.02%), ESGEN Acquisition Co. (1.81%), Kairous Acquisition Corp. Limited (0.16%), Digital Health Acquisition Corp. (0.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Phoenix Biotech Acquisition stock? Short selling PBAX is an investing strategy that aims to generate trading profit from Phoenix Biotech Acquisition as its price is falling. PBAX shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Phoenix Biotech Acquisition? A short squeeze for Phoenix Biotech Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBAX, which in turn drives the price of the stock up even further. How often is Phoenix Biotech Acquisition's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBAX, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies: QOMO Short Squeeze MCAG Short Squeeze BYN Short Squeeze BRAC Short Squeeze WAVS Short Squeeze CETU Short Squeeze YOTA Short Squeeze ESAC Short Squeeze KACL Short Squeeze DHAC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBAX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyI’m afraid WWIII is a very real possibility Porter & CompanyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals